Skip to main navigation Skip to search Skip to main content

A randomised controlled trial of plasmalyte versus normal saline as resuscitation and maintenance fluid therapy for patients presenting with diabetic ketoacidosis (BEST-DKA)BalancEd fluids vs Saline Trial in Diabetic KetoAcidosis

  • Russell, Anthony (Primary Chief Investigator (PCI))
  • Ekinci, Elif (Chief Investigator (CI))
  • Venkatesh, Balasubramanian (Chief Investigator (CI))
  • Hammond, Naomi (Chief Investigator (CI))
  • Keijzers, Gerben (Chief Investigator (CI))
  • Moran, Benjamin (Chief Investigator (CI))

Project: Research

Project Details

Project Description

To determine whether fluid therapy with Plasma-Lyte® 148 increases the number of hospital free days (HFD) up to day 28 compared to 0.9% sodium chloride in patients presenting to the Emergency Department) and deemed to require admission to a critical care area with moderate to severe diabetic ketoacidosis (DKA).
Short titleBalancEd fluids vs Saline Trial in Diabetic KetoAcidosis
AcronymBEST-DKA
StatusActive
Effective start/end date1/01/24 → 31/12/26

Keywords

  • Diabetes
  • Diabetic ketoacidosis